The Efficacy of a New Long-Acting Injectable PrEP
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
Many physicians fear criminalization if state authorities challenge whether their patients qualify under the narrow and vague exceptions in state bans.
Trump has long talked about making the ACA less expensive, but the question is less expensive for whom
The Affordable Care Act (ACA) emerged as an 11th hour debate topic, but neither candidate addressed the health care issue voters want to hear about
What do new Census Bureau data say about the uninsured? The uninsured rate remained at a near historic low of 8.0 % in 2023, per the Current Population Survey.
The start of school was marked by deadly shootings at schools in Georgia and Maryland. Firearms are the leading cause of death among children and adolescents in the U.S.
© 2025 KFF